Treatment of Refractory/Resistant CMV in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management
About this episode
Experts discuss contemporary management strategies for refractory/resistant CMV in hematopoietic cell transplant recipients.
There have been major advances in the management of cytomegalovirus (CMV) infection, one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss considerations for CMV treatment in HCT recipients and examine treatment options for refractory/resistant CMV.
More episodes of Decera Clinical Education Infectious Disease Podcast
- What's New? Simplifying the Complex, Exploring New Approaches in HIV Care for Treatment-Experienced People
- Hepatitis B, Military Service, and the Long Road to Care Podcast: Barriers and Solutions for US Veterans
- Weighty Matters Podcast: A State-of-the-Art Update on Body Habitus Changes in People Living With HIV
- You’re in the Know Podcast: Applying the Latest Advances in Complicated UTI to Practice
- Real-world Data From CROI: What’s New in HIV Care for Treatment-Experienced People
- HIV Update Podcast: Independent Conference Coverage of CROI 2026
Explore listener stats, chart rankings, contacts and more on the Decera Clinical Education Infectious Disease Podcast podcast page.